Andrew A. Krakauer, CEO at CANTEL MEDICAL CORP (CMN), sold 22,981 shares at $54.22 ($1.2M) on 2015-10-14, disclosed to the SEC on 2015-10-14.
Seasonal sale ($1.2M) by CEO — this insider has traded CMN in October in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| TFX | BUY | 2018-08-08 | $238K | — | Filing → |
| CMN | SELL | 2015-12-31 | $590K | — | Filing → |
| CMN | SELL | 2014-12-29 | $815K | — | Filing → |